L. Becker Hewes - 04 Jun 2024 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Signature
/s/ Melissa Masse
Issuer symbol
BPMC
Transactions as of
04 Jun 2024
Net transactions value
-$254,302
Form type
4
Filing time
06 Jun 2024, 16:00:07 UTC
Previous filing
04 Jun 2024
Next filing
04 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Sale $254,302 -2,424 -7.6% $104.91 29,514 04 Jun 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Effected pursuant to a trading plan adopted on March 1, 2024 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.